Phase 2 Trial Results: Weight Loss Outcomes in Type 2 Diabetes At the highest 12 mg dose, adults with type 2 diabetes achieved approximately 16.9% mean body weight reduction from baseline at 24 weeks in a randomised, placebo-controlled phase 2 trial published in The Lancet (2023)
Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction
Lower use of psychiatric medications, particularly selective serotonin reuptake inhibitors (SSRIs), was also observed among incretin-based therapy recipients compared with matched comparator groups
All of those things are really important. The GLP-1 drugs work by targeting hormones in the gut and brain that slow digestion and target appetite and feelings of fullness
Such reports support the hypothesis that therapeutic strategies targeting free radical overproduction are potentially useful to ameliorate the damaging effect of noise on hearing, which leads to cell death, mostly apoptotic (Figure 2)
This technology harnesses various mechanisms, such as high-pressure jets or specialised inhalers, to administer medication directly through the skin without the use of a penetrating needle